LIVZON PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

does not make any representation about the accuracy or completeness of this announcement and expressly disclaims any liability arising out of or in connection with all or any part of this announcement.

We accept no liability for any loss caused by reliance on such content.

Overseas regulatory announcement

This announcement is made in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

This is to set forth the "Livzon Pharmaceutical Group Co., Ltd." published on the website of the Shenzhen Stock Exchange Co., Ltd.’s Board of Directors Audit Committee’s Report on the Performance of Supervision Responsibilities of the Accounting Firm” is for reference only.

By order of the board of directors

Livzon Pharmaceutical Group Co., Ltd. Livzon Pharmaceutical Group Inc.* company secretary Liu Ning

China, Zhuhai March 24, 2026

As of the date of this announcement, the executive director of the company is Mr. Tang Yanggang (vice chairman); the non-executive director of the company is Mr. Zhu Baoguo. Sheng (Chairman), Mr. Lin Nanqi and Mr. Qiu Qingfeng; the company’s employee director is Ms. Ran Yongmei; and the company’s independence is not

The executive directors are Mr. Bai Hua, Mr. Luo Huiyuan, Ms. Cui Lijie and Ms. Wang Zhiyao.

*Identification only

Livzon Pharmaceutical Group Co., Ltd.

Report on the performance of supervisory responsibilities by the audit committee of the board of directors on the accounting firm

According to the "Company Law of the People's Republic of China", "Securities Law of the People's Republic of China" and "Listed Company Governance"

"Guidelines for Self-Regulation of Listed Companies of Shenzhen Stock Exchange No. 1 - Standardized Operations of Companies Listed on the Main Board"

"Work" and other regulations and requirements, the Audit Committee of the Board of Directors of Livzon Pharmaceutical Group Co., Ltd. (referred to as the "Company") In line with the principle of diligence and responsibility, the committee will perform its duties conscientiously and conscientiously, and expresses its sincere gratitude to the company’s 2025 audit institution.

The performance of duties of Grant Thornton Accounting Firm (Special General Partnership) (hereinafter referred to as "Grant Thornton") has been monitored.

Supervise responsibilities. The relevant situation is now reported as follows:

1. Basic situation of accounting firms in 2025 annual audit

(1) Basic information of accounting firms

1. Basic information

Grant Thornton Certified Public Accountants (Special General Partnership) was formerly Beijing Accounting Firm established in 1981. law firm, which was converted into a special general partnership with the approval of the Beijing Municipal Finance Bureau on December 22, 2011, and was changed to a special general partnership in 2012.

Named Grant Thornton LLP (Special General Partnership).

Organizational form: special general partnership

Registered address: 5th Floor, Saite Plaza, No. 22 Jianguomenwai Street, Chaoyang District, Beijing

Chief Partner: Li Huiqi

As of the end of 2025, Grant Thornton has nearly 6,000 employees, including 244 partners and certified public accountants.

There are 1,361 certified public accountants, and more than 400 certified public accountants have signed audit reports on securities services business.

2. Investor protection capabilities

Grant Thornton has purchased occupational insurance with a cumulative compensation limit of 900 million yuan. End of 2024 Occupational Risk Fund

18.7729 million yuan. The provision of occupational risk funds and the purchase of occupational insurance comply with relevant regulations.

Grant Thornton is not required to bear civil liability for any civil litigation related to its practice that has been concluded in the past three years.

3. Integrity record

In the past three years, Grant Thornton has been subject to 0 criminal penalties, 5 administrative penalties, and supervisory and management measures due to professional conduct.

19 times, 13 self-regulatory measures and 3 disciplinary actions. Practitioners have been punished for their professional behavior in the past three years

There were 0 administrative penalties, and 81 employees were punished for their professional behavior, including 6 batches of administrative penalties, There were 20 administrative supervision and management measures, 11 self-regulatory measures and 6 disciplinary sanctions.

(2) Procedures for appointing an accounting firm

The 23rd meeting of the company’s 11th board of directors and the 2024 annual shareholders’ meeting reviewed and approved the “Relevant

"Proposal on Appointing the Company's 2025 Financial Statements and Internal Control Audit Agency", agreed to renew the appointment of Grant Thornton

It is the audit agency for the company's 2025 financial statements and internal controls.

The company's audit committee has a full understanding of Grant Thornton's independence, professional competence, investment

Conduct research on investor protection capabilities and other aspects. After verification, it was unanimously believed that Grant Thornton has the qualifications to provide the company with annual reports, etc.

Qualifications for auditing work, and agreed to propose to the company’s board of directors to re-engage Grant Thornton as the company’s 2025 financial statements

and internal control audit agencies.

2. Performance of accounting firms’ duties in 2025

In accordance with the "Audit Engagement Letter", the "Audit Standards for Chinese Certified Public Accountants" and other professional regulations

Fan and the company's 2025 annual report work arrangements, Grant Thornton's 2025 annual financial report and 2025 12

The effectiveness of the internal control over financial reporting as at 31 March was audited, and the controlling shareholders and other related parties were also audited.

We checked the funds occupied by other parties and issued a special report.

After auditing, Grant Thornton believes that the company's financial statements comply with the Accounting Standards for Business Enterprises in all material respects.

Prepared to fairly reflect the Company’s consolidated and parent company financial position as of December 31, 2025 and 2025

The annual merger and operating results and cash flow of the parent company; on December 31, 2025, the company

"Basic Standards for Industrial Internal Control" and relevant regulations to maintain effective internal control over financial reporting in all material aspects. system. Grant Thornton issued a standard unqualified audit report and an internal control audit report.

In the process of performing audit work, Grant Thornton ensures that the accounting firm and relevant auditors are independent,

Audit plan, risk judgment, audit scope, annual audit focus, node arrangement, preliminary review opinions, etc. are related to the company The audit committee and the company’s management communicated. Grant Thornton advises on all major accounting audit matters of the company

The company reaches a consensus and there are no differences of opinion that cannot be resolved.

3. Supervision of accounting firms by the audit committee

According to the company’s “Terms of Reference of the Audit Committee of the Board of Directors” and other relevant regulations, the Audit Committee of the Board of Directors

The accounting firm's performance of supervisory responsibilities is as follows:

(1) On March 19, 2025, the 10th meeting of the Audit Committee of the 11th Board of Directors reviewed and approved

"Considering the Re-appointment of Grant Thornton Certified Public Accountants LLP (Special General Partnership) as the Company's Audit Agency for 2025"

Establishment Proposal”. The Audit Committee of the Company’s Board of Directors reviewed Grant Thornton’s professional competence, investor protection capabilities,

The company’s independence and integrity status were understood and reviewed, and it was deemed that it has the qualifications to provide audit work for the company. and professional capabilities to meet the requirements of the company's audit work. In order to ensure the continuity and stability of the company's audit work,

Qualitatively, it was agreed to re-appoint Grant Thornton as the company's 2025 financial statements and internal control auditor.

(2) The Audit Committee held communication meetings with Grant Thornton’s accountants through a combination of online and offline methods The meeting discussed the audit plan, audit scope, important time nodes, personnel arrangements, and

The audit focus, audit implementation status, audit adjustment matters and other related matters were communicated.

(3) On March 20, 2026, the company held the 15th meeting of the Audit Committee of the 11th Board of Directors meeting and reviewed and approved the company’s 2025 annual report, financial final accounts report, risk management and internal control self-evaluation

price report and other proposals and agreed to submit them to the board of directors for review.

4. Overall evaluation

The company's audit committee strictly abides by the China Securities Regulatory Commission, Shenzhen Stock Exchange and the "Articles of Association" and "Board of Directors"

"The Terms of Reference of the Audit Committee of the Board of Directors" and other relevant regulations, give full play to the role of professional committees, and provide guidance to accountants

The relevant qualifications and professional capabilities of the firm were reviewed and conducted with the accounting firm during the annual report audit. Conduct adequate discussion and communication, and urge accounting firms to issue audit reports in a timely, accurate, objective and fair manner

report, and effectively fulfilled the audit committee’s supervisory responsibilities over the accounting firm.

The company's audit committee believes that Grant Thornton complies with auditing regulations during the audit of the company's annual report and practices in a fair manner. We conducted an independent audit with a fair and objective attitude, and completed the audit work related to the company’s 2025 annual report on time.

The accounting behavior is standardized and orderly, and the audit reports issued are objective, complete, clear and timely.

Audit Committee of the Board of Directors of Livzon Pharmaceutical Group Co., Ltd.

March 24, 2026